17th Annual World Antibody-Drug Conjugate (ADC) San Diego

17th Annual World Antibody-Drug Conjugate (ADC) San Diego is organized by Hanson Wade and will be held from Oct 12 - 15, 2026 at Town and Country Resort, San Diego, California, United States of America.

Description:
Solidifying ADCs as Standard of Care Therapies by De-Risking Differentiated Payload MoAs Beyond Topo1, Elevating ADCs to Deliver Wider Impact in the Clinical Landscape & Adapting Manufacturing Efficiency for Novel & Cost-Effective ADCs

With groundbreaking clinical impact of traditional ADCs in first-line metastatic indications and ambitions set on neoadjuvant settings, the new era of ADCs are starting to enter the clinic and attract dealmaking attention, unlocking the next wave of differentiated ADCs to redefine the future standard of care in oncology and beyond.

Returning as the largest and definitive ADC congress, the 17^th World ADC San Diego is THE one-stop bioconjugate shop bringing together the global ADC community for an unparalleled amalgamation of case studies, development trends and networking opportunities to forge ADC innovation into differentiated, early-line patient outcomes.

With 7 streams of end-to-end ADC content across  Discovery Chemistry, Discovery Biology, Preclinical, Translational Medicine, Clinical Lessons, Process & Analytical Development, and Manufacturing & Supply Stream, all the ADC innovation will be in the spotlight for an unmissable week of data and insights to de?risk future ADC development and push ADCs into earlier?line oncology treatments.